CFTR and cystic fibrosis: Based on these results, ICM was established as a diagnostic and prognosis test to aid the establishment or refuting a diagnosis of CF, when sweat tests are unclear and/or when the functional consequence of rare or newly detected CFTR mutations are unknown [135].